Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Long-term efficacy, safety and neurotolerability of MATRix regimen followed by autologous transplant in primary CNS lymphoma: 7-year results of the IELSG32 randomized trial.
Leukemia. 2022 Jul;36(7):1870-1878. doi: 10.1038/s41375-022-01582-5. Epub 2022 May 13.
Leukemia. 2022.
PMID: 35562406
Clinical Trial.
IELSG38: phase II trial of front-line chlorambucil plus subcutaneous rituximab induction and maintenance in mucosa-associated lymphoid tissue lymphoma.
Stathis A, Pirosa MC, Orsucci L, Feugier P, Tani M, Ghesquières H, Musuraca G, Rossi FG, Merli F, Guièze R, Gyan E, Gini G, Marino D, Gressin R, Morschhauser F, Cavallo F, Palombi F, Conconi A, Tessoulin B, Tilly H, Zanni M, Cabras MG, Capochiani E, Califano C, Celli M, Pulsoni A, Angrilli F, Occhini U, Casasnovas RO, Cartron G, Devizzi L, Haioun C, Liberati AM, Houot R, Merli M, Pietrantuono G, Re F, Spina M, Landi F, Cavalli F, Bertoni F, Rossi D, Ielmini N, Borgo E, Luminari S, Zucca E, Thieblemont C.
Stathis A, et al. Among authors: ielmini n.
Haematologica. 2024 Feb 22. doi: 10.3324/haematol.2023.283918. Online ahead of print.
Haematologica. 2024.
PMID: 38385243
Free article.
Item in Clipboard
Phase I clinical and pharmacokinetic study of trabectedin and doxorubicin in advanced soft tissue sarcoma and breast cancer.
Sessa C, Perotti A, Noberasco C, De Braud F, Gallerani E, Cresta S, Zucchetti M, Viganò L, Locatelli A, Jimeno J, Feilchenfeldt JW, D'Incalci M, Capri G, Ielmini N, Gianni L.
Sessa C, et al. Among authors: ielmini n.
Eur J Cancer. 2009 May;45(7):1153-1161. doi: 10.1016/j.ejca.2008.11.019. Epub 2008 Dec 27.
Eur J Cancer. 2009.
PMID: 19114300
Clinical Trial.
Item in Clipboard
Phase I clinical and pharmacological evaluation of the multi-tyrosine kinase inhibitor SU006668 by chronic oral dosing.
Sessa C, Viganò L, Grasselli G, Trigo J, Marimon I, Lladò A, Locatelli A, Ielmini N, Marsoni S, Gianni L.
Sessa C, et al. Among authors: ielmini n.
Eur J Cancer. 2006 Jan;42(2):171-8. doi: 10.1016/j.ejca.2005.09.033. Epub 2006 Jan 6.
Eur J Cancer. 2006.
PMID: 16406576
Clinical Trial.
Item in Clipboard
Cite
Cite